(Q90023776)
Statements
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma (English)
Ruiqi Liu
Yuejin Li
Lantian Tian
Huawen Shi
Jiabei Wang
Yingjian Liang
Boshi Sun
Shuangjia Wang
Meng Zhou
Li Wu
Jianhua Nie
Binlin Lin
Shuli Tang
Yanqiao Zhang
Guangyu Wang
Chunhui Zhang
Jiguang Han
Benjie Xu
Lianxin Liu
Kunmei Gong
29 November 2018